News
- Revenue came in at $1.2 billion, missing analyst estimates for Q2 2025. - Net loss per share (GAAP) was $ (0.13) for Q2 2025. - Contract backlog and profitability dropped, but the quarterly dividend ...
CEO William Andrew Hendricks stated that “the second quarter saw several macro events take place that raised the volatility in the oil markets.” He highlighted that oil prices fluctuated between the ...
2d
InvestorsHub on MSNPatterson-UTI Energy Shares Drop Nearly 3% Following Q2 Earnings ShortfallOn Thursday, Patterson-UTI Energy Inc. (NASDAQ:PTEN), a provider of drilling and completion services, reported a ...
Patterson-UTI (PTEN) delivered earnings and revenue surprises of -50.00% and +1.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts are estimating that Patterson-UTI Energy will report an earnings per share (EPS) of $-0.03. Anticipation surrounds ...
We recently published These 10 Stocks Fell Hard. Are You Holding Any? Patterson-UTI Energy, Inc. (NASDAQ:PTEN) is one of this ...
Patterson-UTI Energy, Inc. (NASDAQ:PTEN) is included among the 12 Best Oil and Gas Dividend Stocks to Buy Now. Following its ...
Researchers conducted a population-based cohort study to estimate the prevalence of major thyroid cancer-associated syndromes.
A small number of women (approximately 1%) suffer from premature ovarian failure in which their ovarian follicle reserve is exhausted before age 40. Recent studies in mice show that the absence of ...
Understanding actionable mutations and educating patients on the safety profiles of targeted therapies are essential for the ...
Background: The most commonly reported phenotypes described in patients with PTEN mutations are Bannayan–Riley–Ruvalcaba syndrome (BRRS), with childhood onset, macrocephaly, lipomas and developmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results